FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2125861574> ?p ?o ?g. }

• W2125861574 endingPage "913" @default.
• W2125861574 startingPage "907" @default.
• W2125861574 abstract "In alloimmune thrombocytopenia maternal immunoglobulin G anti-platelet alloantibodies cross the placenta and cause fetal thrombocytopenia. The diagnosis requires laboratory demonstration of incompatibility between a maternal and paternal platelet alloantigen, and detection of maternal antibody to the discordant paternal alloantigen. This disorder should be treated in utero because of its propensity to cause fetal intracranial bleeding. Administration of intravenous immunoglobulin 1 gm/kg/wk to the mother is successful in substantially raising the platelet count in many fetuses, but this is most successful if the count is >20,000/mL3 at the time that the therapy is initiated. The addition of prednisone administered daily to the mother and/or increasing the dose of intravenous immunoglobulin has a therapeutic benefit in cases that have failed to respond to initial therapy with intravenous immunoglobulin alone. The only reliable noninvasive indicator of the potential for severe fetal thrombocytopenia is a history of an antenatal intracranial hemorrhage in a prior affected sibling. Because fetal blood sampling to determine the fetal platelet count may be associated with significant fetal morbidity, attempts are being made to derive a rational, non-invasive, stratified approach to patient-specific therapy of this disorder in affected pregnancies. In alloimmune thrombocytopenia maternal immunoglobulin G anti-platelet alloantibodies cross the placenta and cause fetal thrombocytopenia. The diagnosis requires laboratory demonstration of incompatibility between a maternal and paternal platelet alloantigen, and detection of maternal antibody to the discordant paternal alloantigen. This disorder should be treated in utero because of its propensity to cause fetal intracranial bleeding. Administration of intravenous immunoglobulin 1 gm/kg/wk to the mother is successful in substantially raising the platelet count in many fetuses, but this is most successful if the count is >20,000/mL3 at the time that the therapy is initiated. The addition of prednisone administered daily to the mother and/or increasing the dose of intravenous immunoglobulin has a therapeutic benefit in cases that have failed to respond to initial therapy with intravenous immunoglobulin alone. The only reliable noninvasive indicator of the potential for severe fetal thrombocytopenia is a history of an antenatal intracranial hemorrhage in a prior affected sibling. Because fetal blood sampling to determine the fetal platelet count may be associated with significant fetal morbidity, attempts are being made to derive a rational, non-invasive, stratified approach to patient-specific therapy of this disorder in affected pregnancies." @default.
• W2125861574 created "2016-06-24" @default.
• W2125861574 creator A5049920450 @default.
• W2125861574 creator A5061863697 @default.
• W2125861574 creator A5062688748 @default.
• W2125861574 date "2006-10-01" @default.
• W2125861574 modified "2023-10-14" @default.
• W2125861574 title "Alloimmune thrombocytopenia: State of the art 2006" @default.
• W2125861574 cites W1515377270 @default.
• W2125861574 cites W1981920394 @default.
• W2125861574 cites W1995879559 @default.
• W2125861574 cites W1996917138 @default.
• W2125861574 cites W1997927065 @default.
• W2125861574 cites W2001592943 @default.
• W2125861574 cites W2005202996 @default.
• W2125861574 cites W2028543513 @default.
• W2125861574 cites W2043308724 @default.
• W2125861574 cites W2061033958 @default.
• W2125861574 cites W2064325270 @default.
• W2125861574 cites W2064363923 @default.
• W2125861574 cites W2076260561 @default.
• W2125861574 cites W2094462322 @default.
• W2125861574 cites W2105033197 @default.
• W2125861574 cites W2135779889 @default.
• W2125861574 cites W2158608092 @default.
• W2125861574 cites W2167812720 @default.
• W2125861574 cites W2253884147 @default.
• W2125861574 cites W2266005602 @default.
• W2125861574 cites W2341709626 @default.
• W2125861574 cites W2343853989 @default.
• W2125861574 cites W2435232280 @default.
• W2125861574 cites W83303467 @default.
• W2125861574 doi "https://doi.org/10.1016/j.ajog.2006.05.001" @default.
• W2125861574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16875656" @default.
• W2125861574 hasPublicationYear "2006" @default.
• W2125861574 type Work @default.
• W2125861574 sameAs 2125861574 @default.
• W2125861574 citedByCount "46" @default.
• W2125861574 countsByYear W21258615742012 @default.
• W2125861574 countsByYear W21258615742013 @default.
• W2125861574 countsByYear W21258615742014 @default.
• W2125861574 countsByYear W21258615742015 @default.
• W2125861574 countsByYear W21258615742016 @default.
• W2125861574 countsByYear W21258615742017 @default.
• W2125861574 countsByYear W21258615742019 @default.
• W2125861574 countsByYear W21258615742020 @default.
• W2125861574 crossrefType "journal-article" @default.
• W2125861574 hasAuthorship W2125861574A5049920450 @default.
• W2125861574 hasAuthorship W2125861574A5061863697 @default.
• W2125861574 hasAuthorship W2125861574A5062688748 @default.
• W2125861574 hasConcept C159654299 @default.
• W2125861574 hasConcept C172680121 @default.
• W2125861574 hasConcept C201614185 @default.
• W2125861574 hasConcept C203014093 @default.
• W2125861574 hasConcept C2776953305 @default.
• W2125861574 hasConcept C2779234561 @default.
• W2125861574 hasConcept C2779989375 @default.
• W2125861574 hasConcept C2780898057 @default.
• W2125861574 hasConcept C54355233 @default.
• W2125861574 hasConcept C71924100 @default.
• W2125861574 hasConcept C86803240 @default.
• W2125861574 hasConcept C89560881 @default.
• W2125861574 hasConceptScore W2125861574C159654299 @default.
• W2125861574 hasConceptScore W2125861574C172680121 @default.
• W2125861574 hasConceptScore W2125861574C201614185 @default.
• W2125861574 hasConceptScore W2125861574C203014093 @default.
• W2125861574 hasConceptScore W2125861574C2776953305 @default.
• W2125861574 hasConceptScore W2125861574C2779234561 @default.
• W2125861574 hasConceptScore W2125861574C2779989375 @default.
• W2125861574 hasConceptScore W2125861574C2780898057 @default.
• W2125861574 hasConceptScore W2125861574C54355233 @default.
• W2125861574 hasConceptScore W2125861574C71924100 @default.
• W2125861574 hasConceptScore W2125861574C86803240 @default.
• W2125861574 hasConceptScore W2125861574C89560881 @default.
• W2125861574 hasIssue "4" @default.
• W2125861574 hasLocation W21258615741 @default.
• W2125861574 hasOpenAccess W2125861574 @default.
• W2125861574 hasPrimaryLocation W21258615741 @default.
• W2125861574 hasRelatedWork W125208749 @default.
• W2125861574 hasRelatedWork W2041541548 @default.
• W2125861574 hasRelatedWork W2048232469 @default.
• W2125861574 hasRelatedWork W2059320897 @default.
• W2125861574 hasRelatedWork W2060208887 @default.
• W2125861574 hasRelatedWork W2067428286 @default.
• W2125861574 hasRelatedWork W2109017218 @default.
• W2125861574 hasRelatedWork W2252394786 @default.
• W2125861574 hasRelatedWork W2419153997 @default.
• W2125861574 hasRelatedWork W4288038304 @default.
• W2125861574 hasVolume "195" @default.
• W2125861574 isParatext "false" @default.
• W2125861574 isRetracted "false" @default.
• W2125861574 magId "2125861574" @default.
• W2125861574 workType "article" @default.